Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Consulting agrmnt
Director departure
Appointed director
CC transcript
Notes underwriting agrmnt
Inv. presentation
|
|
Sarepta Therapeutics, Inc. (SRPT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/11/2022 |
SC 13G
| SANDS CAPITAL MANAGEMENT, LLC reports a 6.2% stake in SAREPTA THERAPEUTICS INC |
| 02/11/2022 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 8.3% stake in SAREPTA THERAPEUTICS, INC. |
| 02/16/2021 |
SC 13G
| SANDS CAPITAL MANAGEMENT, LLC reports a 1.2% stake in SAREPTA THERAPEUTICS INC |
| 02/10/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2019 |
SC 13G
| PRICE T ROWE ASSOCIATES INC reports a 6.1% stake in Sarepta Therapeutics, Inc. |
| 02/09/2018 |
SC 13G
| FMR LLC reports a 8.6% stake in SAREPTA THERAPEUTICS INC |
| 12/21/2017 |
SC 13G
| CAPITAL VENTURES INTERNATIONAL reports a 5.4% stake in Sarepta Therapeutics, Inc. |
| 02/23/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/28/2016 |
SC 13G
| Tourbillon Capital Partners, L.P. reports a 6.2% stake in Sarepta Therapeutics, Inc. |
| 05/06/2016 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 5.2% stake in Sarepta Therapeutics, Inc. |
| 04/24/2013 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 5.3% stake in Sarepta Therapeutics, Inc. |
| 11/19/2012 |
SC 13G
| Barry Richard reports a 5.3% stake in Sarepta Therapeutics, Inc. |
| 02/02/2011 |
SC 13G
| AVI BIOPHARMA INC reports a 6.2% stake in AVI BIOPHARMA INC |
| 01/25/2011 |
SC 13G
| AVI BIOPHARMA INC has filed a Schedule 13D for AVI BioPharma, Inc. |
|
|